Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Mutants-of-the-RB-and-P53-genes

 Electroblotting technique for transferring specimens from a polyacrylamide electrophoresis or like gel onto a membrane
What is claimed is: 1. An apparatus especially suitable for transferring a biological specimen from ...


 Probe for electrofusion, electroporation, or like procedure
The present invention provides a structure and method for treating samples in a well tray. Briefly, ...


 Device and method for the electrophoretic separation of macromolecules
The invention relates to an electrophoresis device and an electrophoresis method for the separation ...


 Superfusion apparatus
It is an object of the present invention to provide a superfusion apparatus for use in receptor ...


 Method and apparatus for administration of anticoagulant to red cell suspension output of a blood separator
OF THE PREFERRED EMBODIMENTS Referring now to the drawings, particularly to FIG. 1, there is ...


 Electroporation device
I claim: 1. An electroporation apparatus for electroporating living cells with molecules comprising:...


 Implantable electroporation method and apparatus for drug and gene delivery
Accordingly, it is the primary object of the present invention to provide an improved method of ...


 Flow electroporation chamber with electrodes having a crystalline metal nitride coating
The present invention provides improved electrodes for use in generating an electrical field in a ...


 Solely pollen-specific promoter
What is claimed is: 1. An isolated solely pollen-specific promoter derived from Arabidopsis ...


 Gene transfer using transformed, neodetermined, embryonic cells
This invention relates to the preparation of carrier cells capable of delivering genetic material ...


 Mutants of the RB and P53 genes

Details
Inventors: Fung, Yuen Kai;
Assignee: Research Development Foundation (Carson City, NV)
Primary Examiner: Kemmerer; Elizabeth
Assistant Examiner:
Attorney, Agent or Firm: Adler; Benjamin Aaron

The present invention provides mutants of the Rb and p53 genes and methods utilizing these mutants therapeutically. Along with mutated Rb genes and p53 genes, the present invention provides plasmids containing a mutated Rb gene or a p53 gene. In addition, the present invention provides cells transfected with the plasmids of the present invention. Moreover, the present invention provides for methods of treating a variety of pathophysiological cell proliferative diseases.

DETAILED DESCRIPTION OF THE INVENTION Definitions The term "functional expression of the gene" meant to include the suppression of transcription of the gene, the degradation of the gene transcript (pre-message RNA), the inhibition of splicing, the destruction of the message RNA, the prevention of translation of the message RNA, the prevention of the post-translational modifications of the protein, the destruction of the protein, or the inhibition of the normal function of the protein.
The term "transfected plasmid" is meant to include the bacterial plasmid which contains a mutated retinoblastoma or p53 gene to be carried (transfected) into the cell of choice.
The term"gene therapy" is meant to include the insertion of part or all of a gene, a DNA construct, RNA, or gene product into a cell, group of cells, tissue, pathologic lesion, organ or organism for the purpose of modulating gene expression, and/or function of the gene product.
The term "prophylactic gene therapy" is meant to include genes which may be used for partial or total inhibition or prevention of disease and the spread of disease and also is meant to include genes which may be used to supplement or replace absent or defective negative growth in cell, tissues or germlines.
The term "cell proliferative disease" is meant to include any human or animal disease or disorder, affecting any one or any combination of organs, cavities or body parts, which is characterized by single or multiple local abnormal proliferations of cells, groups of cells or tissue(s), whether benign or malignant.
The term "prokaryote" is meant to include all bacteria which can be transformed with the DNA for the expression of the recombinant molecules of the present invention.
The term "eukaryote" is meant to include all yeasts, fungi, animal and plant cells which can be transformed with the DNA for the expression of the recombinant molecules of the present invention.
The DNA for DNA constructs of the present invention can be synthetic or may be derived from any mammalian species



Related patents
  Oncolytic virus therapy
OF THE INVENTION As used herein the term "human cells" means cells isolated from a human, or cultured cells that have been derived from cells isolated from a human and/...
  Covalently cross-linked oligonucleotides
OF THE INVENTION In accordance with the objects of this invention novel, covalently cross-linked oligonucleotide strands are disclosed. Preferably such strands are "...
  Methods of inducing cancer cell death and tumor regression
The present invention provides methods of treating cancer in a patient (e.g., a mammal such as a human) in need of such treatment, comprising administering an effective ...
  Injectable hyaluronic acid derivative with pharmaceuticals/cells
OF THE INVENTION The present invention concerns injectable, biocompatible and biodegradable compositions containing at least one hyaluronic acid benzyl ester derivative ...
  Modification of polymer surfaces and molecular immobilization by photoreaction
OF THE INVENTION To obviate disadvantages associated with the modification methods presently existing, the object of the present invention is to provide a method for ...
  Wound and skin care compositions
What is claimed: 1. A composition comprising a dermatologically acceptable carrier and an effective amount of a hydroxy acid compound, present in a concentration of ...
  Water treatment apparatus
The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: 1. Water purification apparatus for purifying dirty water,...
  Membrane cell
What we claim is: 1. A monopolar filter press electrolytic cell suitable for use in the electrolysis of an aqueous alkali metal halide solution (brine) to produce an ...
  Encapsulating biological active substances into erythrocytes
We claim: 1. A process for the encapsulation in human or animal erythrocytes of at least one substance having a biological activity utilizing a dialysis element having a ...
  Flow chamber and electro-manipulator incorporating same
Accordingly, an object of the present invention is to provide a flow chamber and an electro-manipulator incorporating the same which can be operated easily, and which ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved